All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 86 points (0.5%) at 17,915 as of Tuesday, Nov. 3, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,603 issues advancing vs. 1,362 declining with 155 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Fresenius Medical Care AG & Co. KGaA ( FMS), up 2.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Becton Dickinson ( BDX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Becton Dickinson is up $1.27 (0.9%) to $146.08 on light volume. Thus far, 321,029 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $143.83-$146.31 after having opened the day at $143.83 as compared to the previous trading day's close of $144.81.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. Becton Dickinson has a market cap of $30.0 billion and is part of the health care sector. Shares are up 4.1% year-to-date as of the close of trading on Monday. Currently there are 10 analysts who rate Becton Dickinson a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Becton Dickinson Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Baxter International ( BAX) is up $0.39 (1.0%) to $38.16 on light volume. Thus far, 1.3 million shares of Baxter International exchanged hands as compared to its average daily volume of 8.5 million shares. The stock has ranged in price between $37.60-$38.20 after having opened the day at $37.60 as compared to the previous trading day's close of $37.77.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $20.4 billion and is part of the health care sector. Shares are up 3.1% year-to-date as of the close of trading on Monday. Currently there is 1 analyst who rates Baxter International a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Baxter International Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Medtronic ( MDT) is up $0.71 (0.9%) to $76.46 on light volume. Thus far, 2.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 6.5 million shares. The stock has ranged in price between $75.29-$76.46 after having opened the day at $75.66 as compared to the previous trading day's close of $75.75.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medtronic plc manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $104.5 billion and is part of the health care sector. Shares are up 4.9% year-to-date as of the close of trading on Monday. Currently there are 13 analysts who rate Medtronic a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Medtronic Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).